Latest news
Socrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Study - HCPLiveHCPLive · Fri, 07 Aug 2026 23:10:36 GMTFDA to hold adcomm for Grail cancer test that failed in large, randomized trial - Endpoints NewsEndpoints News · Fri, 07 Aug 2026 16:08:00 GMTOral TYK2 Inhibitor Socrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Trial - Dermatology TimesDermatology Times · Fri, 07 Aug 2026 16:04:43 GMTCMPS Stock Rises 23% Pre-Market As Compass Achieves Primary Endpoint In Phase 3 Treatment-Resistant Depression Trial - StocktwitsStocktwits · Fri, 07 Aug 2026 15:54:57 GMTAltimmune’s Investigational Therapy For Alcohol Use Disorder Meets Primary Endpoint – ALT Stock Jumps 10% - StocktwitsStocktwits · Fri, 07 Aug 2026 14:25:47 GMTNamilumab Fails to Meet Primary End Point in Pulmonary Sarcoidosis - HCPLiveHCPLive · Fri, 07 Aug 2026 14:06:13 GMTMicot Pharma's MT200605 Achieves Primary Endpoint in Phase II Trial, Novel Integrated Multi-stage Neuroprotection Mechanism to Be Presented at WSC 2026 - FinancialContentFinancialContent · Fri, 07 Aug 2026 08:36:00 GMTBioVie shares halve on murky Parkinson’s disease readout - BioSpaceBioSpace · Thu, 06 Aug 2026 18:37:26 GMT